Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Low Dose Ketamine in Nasal Surgery
NCT05828199Phase 1Unknown
- Sponsor
- Al-Azhar University
- Start
- Dec 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of dexmedetomidine and ketamine in postoperative pain and intraoperative bleeding (2 arms), sponsored by Al-Azhar University. Primary endpoint: Postoperative pain. Status: unknown.
02
Drugs
dexmedetomidineketamine
03
Conditions
postoperative painintraoperative bleeding
Beyond the preview
Go deeper on NCT05828199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05828199.